What is IQVIA's cash & equivalents?

IQVIA (IQV) reported cash & equivalents of $1.95B in Q1 2026.

How has IQVIA's cash & equivalents changed year-over-year?

IQVIA's cash & equivalents increased by 11.9% year-over-year, from $1.74B to $1.95B.

What is the long-term trend for IQVIA's cash & equivalents?

Over 5 years (2020 to 2025), IQVIA's cash & equivalents has grown at a 1.8% compound annual growth rate (CAGR), from $1.81B to $1.98B.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

IQVIA IQV Cash & Equivalents

Cash & Equivalents at other companies

Thermo Fisher ScientificTMO

$3.28B-21.4%

UnitedHealth GroupUNH

$28B-8.8%

Labcorp HoldingsLH

$981.1M+166%

CognizantCTSH

$1.5B-24.0%

OracleORCL

$31.29B+190%

Veeva SystemsVEEV

$1.9B-3.5%

Other financials

Income statement

See full

Revenue$4.2B+8.4%

Gross profit$1.4B+4.4%

Operating income$514.0M+3.6%

Net income$274.0M+10.0%

EPS (diluted)$1.61+15.0%

Balance sheet

See full

Total debt$16.1B+10.7%

Total equity$6.2B+4.1%

Total assets$29.7B+8.6%

Cash flow

See full

Operating cash flow$618.0M+8.8%

CapEx$127.0M-10.6%

Free cash flow$491.0M+15.3%

Valuation

See full

Market cap$31.9B+17.5%

Enterprise value$46.02B+12.8%

P/E23×+1.1×

P/S1.9×+0.2×

Profitability

See full

Gross margin33%-1.7pp

Operating margin13.2%-0.9pp

Net margin8.3%-0.3pp

FCF margin12.7%-1.2pp

Returns & leverage

See full

Return on equity22.7%+1.1pp

Debt / equity2.6×+0.2×

Current ratio0.7×-0.1×

Where this comes from

Reported directly by IQVIA in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: IQVIA’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about IQVIA's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is IQVIA's cash & equivalents?: IQVIA (IQV) reported cash & equivalents of $1.95B in Q1 2026.
How has IQVIA's cash & equivalents changed year-over-year?: IQVIA's cash & equivalents increased by 11.9% year-over-year, from $1.74B to $1.95B.
What is the long-term trend for IQVIA's cash & equivalents?: Over 5 years (2020 to 2025), IQVIA's cash & equivalents has grown at a 1.8% compound annual growth rate (CAGR), from $1.81B to $1.98B.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.